Friday - April 4, 2025
DEA Seeks Public Comment on SpecGx LLC's Controlled Substances Import Application
March 27, 2025
WASHINGTON, March 27 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has announced that SpecGx LLC, a pharmaceutical company based in St. Louis, Missouri, has applied for registration as an importer of several controlled substances, including Thebaine, raw opium, coca leaves, and Tapentadol. The application was published in the Federal Register on March 27, 2025, under Docket No. DEA1516, and the public is invited to submit comments or request a hearing on the mat . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products